Navigation Links
OES BF-1T60 Fiberoptic Bronchoscope

ProductsOES BF-1T60 Fiberoptic Bronchoscope
Company Olympus America Medical
Item OES BF-1T60 Fiberoptic Bronchoscope
Features 
  • 5.9mm distal tip and 6.0mm insertion tube.
  • Wide 120 field of view.
  • 1800/1300 up/down angulation.
  • 600mm working length.
  • Ultra compact fiberoptic bundle for clearer image.
  • Diathermy compatible.
    • Description High performance fiberoptic imaging from the latest 60 series bronchoscopes.

    Olympus has improved its fiberscope range, focussing on providing clinicians with superior specifications and enhanced image performance. Olympus has a impressive range of fiberoptic instruments for diagnosis and therapy in the respiratory tract to meet the demands of increasing peripheral bronchoscopy.

    Large 3.0mm channel allows the selection of a wide range of EndoTherapy devices ideal for BAL and emegency procedures.
    Info Olympus America Medical
    Customer Service: (800) 848-9024
    Web site: http://www.olympusamerica.com

    Related medicine products :

    1. Coaxial Fiberoptic Headlights
    2. Fiberoptic Lightweight Coaxial Rotary Headlight
    3. Neuroview Rigid Body Fiberoptic Neuroendoscopes
    4. Fiberoptic CIS Set
    5. Fiberoptic Light Guide, snap-on
    6. Fiberoptic Light Guide, clip-on
    7. High Transmission Autoclavable Fiberoptic Light Guide, snap-on
    8. High Transmission Autoclavable Fiberoptic Light Guide, with 45 angled instrument fitting, snap-on
    9. Fiberoptic Light Guide with Fixed ACMI™ Light Source End
    10. Universal Fiberoptic Light Guide (without adapters)
    11. Fiberoptic Green System Laryngoscope Handles
    Breaking Medicine Technology:Berger & Montague, P.C., Files Class Action Against Hemispherx Biopharma, Inc. Extending the End of the Class Period to December 1, 2009, When the Company Announced That the FDA Found No Evidence of Efficacy of Its Drug 2Berger & Montague, P.C., Files Class Action Against Hemispherx Biopharma, Inc. Extending the End of the Class Period to December 1, 2009, When the Company Announced That the FDA Found No Evidence of Efficacy of Its Drug 3DecisionView Launches StudyOptimizer(TM) 4 2DecisionView Launches StudyOptimizer(TM) 4 3Echo Therapeutics Announces Consulting Agreement with Hayden IR to Develop and Implement a Strategic Investor Relations Campaign 2Echo Therapeutics Announces Consulting Agreement with Hayden IR to Develop and Implement a Strategic Investor Relations Campaign 310 Things to do This Summer 21 48398 110 Things to do This Summer 21 48398 210 Things to do This Summer 21 48398 3Naps with rapid eye movement sleep increase receptiveness to positive emotion 48396 1Naps with rapid eye movement sleep increase receptiveness to positive emotion 48396 2Caribbean coral reefs flattened 8781 1Caribbean coral reefs flattened 8781 2